Rational design of peptides against glyceraldehyde-3-phosphate dehydrogenase as potential candidates for the treatment of paracoccidioidomycosis

Vol. 1, 2019 - 108968
Poster and Oral (selected)
Favorite this paper
How to cite this paper?
Abstract

Paracoccidioides is a dimorphic fungus, the causative agent of paracoccidioidomycosis. It is endemic within Latin America. The treatment is based on azoles, sulfonamides and amphotericin B. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a glycolytic enzyme categorized as a moonlight protein. The study of protein-protein interaction adds knowledge related to protein function and helps to characterize protein complexes. Here, we show the GAPDH interactome in different phases of P. lutzii and an in silico validation of 18 proteins that bound to GAPDH. We modeled the GAPDH 3-D structure, performed molecular dynamics and docking in order to identify the interacting interface between GAPDH. Several proteins bound to GAPDH from mycelium, transition and yeast are common to important pathways such as glycolysis and TCA. GAPDH has four main regions of contact with interacting proteins. Modulating peptides were designed according to these main regions of interaction in order to be tested as new antifungal treatment.

Track
  • 1. Strategies in Drug Design
Keywords
GAPDH
PARACOCCIDIOIDES
peptide design
antifungals